Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paraneoplastic cerebellar degeneration

J B Posner1

  • 1Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Les syndromes paranéoplasiques.

Revue neurologique·2002
Same author

The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2001
Same author

Molecular and clinical diversity in paraneoplastic immunity to Ma proteins.

Annals of neurology·2001
Same author

Yet another paraneoplastic antibody.

Annals of neurology·2001
Same author

Spontaneous intracranial hypotension: the broadening clinical and imaging spectrum of CSF leaks.

Neurology·2001
Same author

Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies.

Neurology·2000

Paraneoplastic cerebellar degeneration is a rare cancer complication causing rapid pancerebellar dysfunction. Autoantibodies targeting tumor and Purkinje cells suggest an autoimmune mechanism in this condition.

Area of Science:

  • Neuroscience
  • Oncology
  • Immunology

Background:

  • Paraneoplastic cerebellar degeneration (PCD) is a rare neurological complication associated with various cancers.
  • It is particularly linked to small cell lung cancer, gynecologic cancers, and Hodgkin's disease.
  • PCD is characterized by rapid, often irreversible, pancerebellar dysfunction.

Purpose of the Study:

  • To describe the clinical and pathological features of paraneoplastic cerebellar degeneration.
  • To investigate the potential autoimmune mechanisms underlying PCD.
  • To explore the role of autoantibodies in the pathogenesis of PCD.

Main Methods:

  • Clinical case reviews and pathological examination of affected individuals.
  • Analysis of patient serum and spinal fluid for the presence of autoantibodies.

Related Experiment Videos

  • Correlation of autoantibody presence with tumor type and clinical presentation.

    • Main Results:

    • PCD involves the loss of Purkinje cells, with or without inflammatory infiltrates.
    • Autoantibodies reacting with tumor and Purkinje cells are identified in some patients.
    • The presence of these autoantibodies suggests, but does not confirm, an autoimmune pathogenesis.

    Conclusions:

    • Paraneoplastic cerebellar degeneration is a distinct neurological syndrome linked to cancer.
    • Autoantibodies may play a role in the autoimmune pathogenesis of PCD.
    • Further research is needed to definitively establish the autoimmune mechanism and therapeutic targets.